Delivery Order SPE2DB20D3101-SPE2DB25FQYB1

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,747.54 firm fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution in 200 ml vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities to...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $2,433.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lacosamide 10 mg/ml solution in 200 ml bottles, a prescription medication used to treat certain types of epilepsy. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of December 3, 2024. It is not designated as a...
This firm-fixed-price delivery order with a ceiling value of $3,183.54 was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lacosamide 10 mg/ml solution in 200 ml vials, with a period of performance through November 29, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200ml quantities, a generic medication used for the treatment of epilepsy and neuropathic pain. The contract has a firm fixed price of $1,370.40 and a completion date of November 14, 2024. This appears to be a delivery order under a larger Indefinite Delivery...
This federal contract award is for the delivery of Lacosamide 10 mg/mL solution in 200 mL bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,574.15, was awarded to the Amerisourcebergen Drug Corporation's Corporate Office Division on April 23, 2024, with a completion date of April 24, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor that holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.44 firm-fixed-price delivery order is for the supply of 200 milliliter bottles of a 10 milligram per milliliter solution of the medication lacosamide. The award is not set aside for any particular business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Lacosamide 100 mg/10 ml pharmaceutical products, with an ultimate completion date of April 2, 2024 and a ceiling value of $1,000.12. Amerisourcebergen Drug Corporation, through its Corporate Office...
This federal contract award is for the supply of Lacosamide 10 mg/ml solution, a prescription medication, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp. The contract is a delivery order with a firm fixed-price of $2,517.72 and an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4565662476 Lacosamide 10 mg/ml solution in 200 ml containers. The contract has a ceiling value of $1,013.31 and is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with no set-aside designation. It has an ultimate completion date of September 4, 2024. Amerisourcebergen, one of the largest...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQYB1
    Delivery Order

This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 3/31/25, 9:38 AM